Head-to-head · Cost-Efficiency Index
Allara Health vs Livea
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Allara Health
Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself.
Visit Allara HealthLivea
Cost-first shoppers who want mN/WI residents wanting in-person clinic access, or telehealth patients in MN, WI, IA, or FL.
Visit LiveaThe verdict
Allara Health and Livea tie on the Cost-Efficiency Index at 62/100, so neither wins outright on the numbers. For most shoppers we'd start with Allara Health (ranked #204, a hair above #208) — Cost-first shoppers who want insured patients who want women's hormonal-health specialists to manage a GLP-1 prescription, not shoppers pricing the drug itself. But Livea is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Allara Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Allara Health | Livea |
|---|---|---|
| Cost-Efficiency Index | 62/100 | 62/100 |
| Semaglutide / mo | $149/mo (plus a separate fee, brand-name) | $99/mo (starting dose, compounded) |
| Tirzepatide / mo | Not disclosed | $199/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,788 | $1,188 |
| Tirzepatide / yr (modeled) | — | $2,388 |
| Coverage | Coverage not published | 4 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #204 | #208 |
Allara Health
62/100Where the value is
- In-network with major insurers (Aetna, Blue Cross Blue Shield/Anthem/Carefirst, Cigna, United Healthcare/Oxford/UMR, GEHA), which can make branded GLP-1s cheaper than any cash-pay compounded option for covered patients
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound) rather than unapproved compounded preparations
- Board-certified OB-GYNs, endocrinologists, and Registered Dietitians on a women's-health-specialized platform
The tradeoffs
- No GLP-1 medication price is published anywhere on the site — the $149/mo figure is a visit/membership fee only, and actual drug cost depends entirely on insurance or is undisclosed for self-pay
- Not a general low-cost GLP-1 shopping option — the platform is built around women's hormonal/PCOS specialty care, with GLP-1 as one treatment among many
Livea
62/100Where the value is
- Hybrid model offers real in-person clinic locations (8 across MN & WI), not telehealth-only
- Low headline starting price for semaglutide ($99/mo)
- Broader wellness service menu (nutrition, hormone therapy, NAD+) beyond just GLP-1s
The tradeoffs
- Tirzepatide explicitly flagged 'when available,' implying inconsistent supply
- No named medical director or specific compounding pharmacy partner
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.